Hanall Biopharma (009420) Filing History

OverviewFinancialsChecksFilings
DateFiling
2026-08-14Semi-Annual Report (2026.06)
2026-07-31Corporate Briefing (IR) (Informational Disclosure)
2026-07-29Consolidated Operating (Preliminary) Earnings (Fair Disclosure)
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice